Explore emerging evidence for possible subtypes of PMDD and PME in this webinar with Dr. Tory Eisenlohr-Moul and Hafsah Tauseef of the CLEAR Lab (UIC). Learn what PMDD and PME are, why subtype research matters, and how group-based trajectory modeling reveals distinct patterns of symptom change. Discover key findings, future research needs, and what this could mean for patients.